Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

TSolution One® Total Knee Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03017261
Recruitment Status : Completed
First Posted : January 11, 2017
Last Update Posted : July 24, 2019
Sponsor:
Collaborators:
Musculoskeletal Clinical Regulatory Advisers
Medical Metrics Diagnostics, Inc
Information provided by (Responsible Party):
Think Surgical Inc.

Brief Summary:
The goal of this prospective, non‐randomized, multicenter clinical trial is to determine whether robotic‐assisted total knee arthroplasty performed with TSolution One® System is safe and effective for use as an alternative to the conventional manual techniques. Clinical and radiographic outcomes for robotic‐assisted total knee arthroplasty performed with the TSolution One® System will be collected preoperatively, intraoperatively, and postoperatively up to a follow‐up period of no less than 6 months and no more than 12 months. These outcomes will be compared to the ones reported in the literature for conventional manual techniques.

Condition or disease Intervention/treatment Phase
Osteoarthritis, Knee Device: TSolution One® Not Applicable

Detailed Description:

This clinical investigation will be conducted as a prospective, non‐randomized, multicenter study. The primary objective of this study is to demonstrate that the TSolution One System is safe and effective for use as an alternative to manual planning and sawing/cutting techniques. The primary effectiveness objective of this study is to demonstrate that the TSolution One® System is effective for use as an alternative to manual planning and sawing/cutting techniques by comparing the rate of malalignment for mechanical axis greater than 3° at 3 months to the rate reported in the literature (i.e. 32%) and to demonstrate significant clinical benefit by reducing the number of malaligned patients by at least 50% (i.e. from 32% to ≤ 16%). The safety objective of this study is based on the rate of intraoperative and postoperative TKA complications, with a follow-up period of no less than 6 months and no more than 12 months, and to compare this rate to the rate reported in the literature. The secondary objective of this study is to summarize the distribution of improvements in patients' self-reported assessment of postoperative function and quality-of-life from baseline to a maximum of 12 months. Additionally, other preoperative planning alignment goals (e.g. Knee V‐V Alignment; Femoral Joint Line Alignment Angle; Tibial Joint Line Alignment Angle; Tibial Slope Angle) will be compared to the post‐operative alignment at 3 months.

Investigators will recruit subjects from patients in their practice who require unilateral total knee arthroplasty. Patients will be screened to identify eligible candidates based on the inclusion and exclusion criteria. A total of one hundred fifteen (115) patients will be enrolled in the study across the participating sites. All patients will sign an informed consent form prior to participating in the study.

Prior to undergoing the investigational procedure, the patients will complete baseline surveys of function and quality of life (Knee Society Score survey and the SF‐12 Health Survey) and have baseline radiographs and a CT scan of the knee.

Each patient will then undergo robotic‐assisted total knee arthroplasty with the TSolution One® System. The investigators will evaluate intra‐ and postoperative complications. Postoperative radiographs and a CT scan will be used to measure limb alignment using a standardized radiographic evaluation protocol. Each patient will complete a postoperative Knee Society Score survey and the SF‐12 Health Survey to assess functional outcomes and quality‐of‐life following the investigational procedure.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 115 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: TSolution One® Total Knee Arthroplasty Clinical Trial
Actual Study Start Date : February 8, 2017
Actual Primary Completion Date : June 26, 2019
Actual Study Completion Date : June 26, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Knee Replacement

Arm Intervention/treatment
Experimental: TSolution One®
This group will undergo total knee arthroplasty with the TSolution One® System for the preparation of the femoral and tibial cuts.
Device: TSolution One®
Total knee arthroplasty with the TSolution One® System for the preparation of the femoral and tibial cuts.




Primary Outcome Measures :
  1. Comparison between Planned and Postoperative Coronal Limb Alignment [ Time Frame: 3 months follow-up ]
    Comparison between planned and postoperative coronal limb alignment will be assessed as the difference between the planned hip-knee-ankle angle and the achieved hip-knee-ankle angle after surgery.

  2. Adverse Events [ Time Frame: Up to 12 months follow-up ]
    Adverse events will be assessed as the percentage of patients with TCAT‐assisted implantation experiencing the composite safety endpoint of typical adverse events


Secondary Outcome Measures :
  1. Bleeding Complications [ Time Frame: Up to 12 months follow-up ]
    Bleeding complications will be assessed based on the incidence of transfusions required (autologous or allogenic).

  2. Knee Society Score [ Time Frame: Baseline and up to 12 months follow-up ]
    Difference in scores before and after the surgery will be computed.

  3. SF-12 score [ Time Frame: Baseline and up to 12 months follow-up ]
    Difference in scores before and after the surgery will be computed.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. At least 21 years of age.
  2. Skeletally mature, as evidenced by closed epiphyses.
  3. Eligible for primary unilateral TKA due to osteoarthritis defined radiographically by a Kellgren‐Lawrence Grade of 3 or higher.
  4. Able to understand and willing to comply with the requirements of the study.
  5. Able to give voluntary, written informed consent to participate and has signed an Informed Consent Form specific to this study.

Exclusion Criteria:

  1. Has undergone previous open knee surgery in the operative knee.
  2. Has a body mass index (BMI) > 40 kg/m2.
  3. Is a candidate for bilateral TKA.
  4. Has a coronal deformity greater than 20° or a sagittal flexion contracture greater than 15°.
  5. Has an active systemic infection or an active local infection in or near the operative knee joint, or has a previous history of joint infection.
  6. Has a pathological skeletal condition or skeletal immaturity which would significantly compromise the ability of the bone to withstand the stress required for preparation of the bones and proper implantation of the prostheses (e.g., severe osteoporosis, Paget's disease, renal osteodystrophy, AVN, sickle cell disease, etc.).
  7. Has femoral or tibial bone stock that is of poor quality or inadequate to provide stability for femoral or tibial fixation.
  8. Has any type of metallic implant in the operative leg.
  9. Has a known or suspected sensitivity to any of the materials in the investigational device or implant components (i.e. cobalt, chromium, titanium, stainless steel, titanium nitride, aluminum, polyethylene, PVC plastic)
  10. Has a systemic illness or a neuromuscular, neurosensory, or musculoskeletal deficiency that would render the patient unable to perform appropriate postoperative rehabilitation.
  11. Has a neuromuscular disorder that would create an unacceptable risk of prosthesis instability or fixation failure.
  12. Has significant comorbidities or conditions associated with high risk for surgical or anesthetic survival (e.g. peripheral vascular disease, unstable cardiac disease, poorly controlled diabetes, immunosuppression, etc.).
  13. Is pregnant or intends to become pregnant during the course of the study.
  14. Has previously experienced a stroke.
  15. Is participating concurrently in another clinical trial, or has participated in a clinical trial within the last 90 days, or intends to during the course of the study.
  16. Has a medical or psychiatric condition which, in the opinion of the investigator, poses a risk of the patient being unable to complete the study or presents risks associated with study participation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03017261


Locations
Layout table for location information
United States, New Jersey
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
United States, New York
NYU Langone Medical Center
New York, New York, United States, 10016
St. Francis Hospital
New York, New York, United States, 11576
United States, North Carolina
North Carolina Specialty Hospital
Durham, North Carolina, United States, 27704
United States, Ohio
St. Vincent Charity Medical Center
Cleveland, Ohio, United States, 44115
United States, Texas
Houston Methodist West Hospital
Houston, Texas, United States, 77094
Sponsors and Collaborators
Think Surgical Inc.
Musculoskeletal Clinical Regulatory Advisers
Medical Metrics Diagnostics, Inc
Investigators
Layout table for investigator information
Principal Investigator: Bernard N Stulberg, MD St. Vincent Charity Medical Center

Layout table for additonal information
Responsible Party: Think Surgical Inc.
ClinicalTrials.gov Identifier: NCT03017261    
Other Study ID Numbers: 16-PROTO-01
First Posted: January 11, 2017    Key Record Dates
Last Update Posted: July 24, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: Yes
Keywords provided by Think Surgical Inc.:
Osteoarthritis
Arthroplasty
Robotic Surgery
Knee
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases